Clinical Trial Update: Effect of Henagliflozein on Hepatic Fat Content in Patients With T2DM and NAFLD [Phase 4]

View source ↗

Summary

This clinical trial update describes an ongoing Phase 4 study evaluating Henagliflozein's effect on hepatic fat content in patients with type 2 diabetes mellitu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Fatty Liver Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Henagliflozein (Henagliflozein)

Snippet

Sponsor: Zhujiang Hospital | Conditions: Type2 Diabetes Mellitus, Nonalcoholic Fatty Liver Disease | Phase 4 | Status: RECRUITING